Below are the most recent publications written about "Gene Dosage" by people in Profiles.
-
McCormick BK, Barbash DA, Clark AG. The Stellate meiotic drive system of Drosophila melanogaster is active in contemporary populations. Genetics. 2026 Aug 05; 233(4).
-
Robles-Bolivar P, B?chinger D, Bose A, Ramirez K, Brown A, Juliano AF, Lopez-Escamez JA, Kujawa SG, Liu ES, Amr SS, Rauch SD, Eckhard AH, Chari DA. Association of PHEX Gene Dosage With Meniere Disease and Related Audiovestibular Phenotypes in X-Linked Hypophosphatemia. JAMA Otolaryngol Head Neck Surg. 2026 May 01; 152(5):452-464.
-
Larsen EC, Moon JE, King OD, Lawrence JB. Selective chr21 homolog silencing reveals polymorphisms influence the epigenetic silencing and functional dosage of RWDD2B. Am J Hum Genet. 2026 Apr 02; 113(4):715-735.
-
Amin ND, Senturk G, Costaguta G, Driscoll S, O'Leary B, Bonanomi D, Pfaff SL. A hidden threshold in motor neuron gene networks revealed by modulation of miR-218 dose. Neuron. 2021 10 20; 109(20):3252-3267.e6.
-
Schmidt TM, Fonseca R, Usmani SZ. Chromosome 1q21 abnormalities in multiple myeloma. Blood Cancer J. 2021 04 29; 11(4):83.
-
Nand A, Zhan Y, Salazar OR, Aranda M, Voolstra CR, Dekker J. Genetic and spatial organization of the unusual chromosomes of the dinoflagellate Symbiodinium microadriaticum. Nat Genet. 2021 05; 53(5):618-629.
-
Gortakowski M, Feghali K, Osakwe I. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules. Thyroid. 2021 09; 31(9):1376-1382.
-
Tantiwetrueangdet A, Panvichian R, Sornmayura P, Leelaudomlipi S, Macoska JA. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues. BMC Cancer. 2021 Mar 20; 21(1):295.
-
Hwang S, Cavaliere P, Li R, Zhu LJ, Dephoure N, Torres EM. Consequences of aneuploidy in human fibroblasts with trisomy 21. Proc Natl Acad Sci U S A. 2021 02 09; 118(6).
-
Moisse M, Zwamborn RAJ, van Vugt J, van der Spek R, van Rheenen W, Kenna B, Van Eijk K, Kenna K, Corcia P, Couratier P, Vourc'h P, Hardiman O, McLaughin R, Gotkine M, Drory V, Ticozzi N, Silani V, de Carvalho M, Mora Pardina JS, Povedano M, Andersen PM, Weber M, Basak NA, Chen X, Eberle MA, Al-Chalabi A, Shaw C, Shaw PJ, Morrison KE, Landers JE, Glass JD, Robberecht W, van Es M, van den Berg L, Veldink J, Van Damme P. The Effect of SMN Gene Dosage on ALS Risk and Disease Severity. Ann Neurol. 2021 04; 89(4):686-697.